AMY1C | Amylase, alpha 1C (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMY2A | Amylase, alpha 2A (pancreatic) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
AMY2B | Amylase, alpha 2B (pancreatic) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ANAPC5 | Anaphase promoting complex subunit 5 | | | | | | Expressed in all |
ANGEL1 | Angel homolog 1 (Drosophila) | Predicted secreted proteins
| | | | | Expressed in all |
ANGPT1 | Angiopoietin 1 | Cancer-related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
ANGPT2 | Angiopoietin 2 | Cancer-related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
ANGPT4 | Angiopoietin 4 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ANGPTL1 | Angiopoietin-like 1 | Predicted secreted proteins
| | | | | Mixed |
ANGPTL2 | Angiopoietin-like 2 | Predicted secreted proteins
| | | | | Mixed |
ANGPTL3 | Angiopoietin-like 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ANGPTL4 | Angiopoietin-like 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANGPTL5 | Angiopoietin-like 5 | Predicted secreted proteins
| | | | | Tissue enriched |
ANGPTL6 | Angiopoietin-like 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANK1 | Ankyrin 1, erythrocytic | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANKAR | Ankyrin and armadillo repeat containing | Predicted membrane proteins
| | | | | Expressed in all |
ANKDD1A | Ankyrin repeat and death domain containing 1A | Predicted secreted proteins
| | | | | Mixed |
ANKIB1 | Ankyrin repeat and IBR domain containing 1 | Predicted secreted proteins
| | | | | Expressed in all |
ANKRD33 | Ankyrin repeat domain 33 | | | | | | Tissue enriched |
ANKRD60 | Ankyrin repeat domain 60 | Predicted secreted proteins
| | | | | Tissue enriched |
ANO7 | Anoctamin 7 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANTXR1 | Anthrax toxin receptor 1 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
AOAH | Acyloxyacyl hydrolase (neutrophil) | Enzymes Predicted secreted proteins
| | | | | Mixed |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AOC2 | Amine oxidase, copper containing 2 (retina-specific) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AOC3 | Amine oxidase, copper containing 3 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AP000721.4 | Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
APBB1 | Amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
APCDD1 | Adenomatosis polyposis coli down-regulated 1 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APLP2 | Amyloid beta (A4) precursor-like protein 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOA1BP | Apolipoprotein A-I binding protein | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
APOA2 | Apolipoprotein A-II | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOC1 | Apolipoprotein C-I | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC4 | Apolipoprotein C-IV | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOE | Apolipoprotein E | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
APOH | Apolipoprotein H (beta-2-glycoprotein I) | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOOL | Apolipoprotein O-like | Predicted secreted proteins
| | | | | Expressed in all |
AQPEP | Aminopeptidase Q | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ARCN1 | Archain 1 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ARFIP2 | ADP-ribosylation factor interacting protein 2 | Predicted secreted proteins
| | | | | Expressed in all |
ARHGAP23 | Rho GTPase activating protein 23 | | | | | | Expressed in all |
ARHGAP25 | Rho GTPase activating protein 25 | Plasma proteins
| | | | | Tissue enhanced |